carbamates has been researched along with naloxone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pleuvry, BJ; Tobias, MA | 1 |
| Emig, P; Engel, J; Nickel, B; Szelenyi, I; Weischer, CH | 1 |
| Trezza, V; Vanderschuren, LJ | 1 |
| Allen, CP; Lang, ST; Leri, F; Manwell, LA; Parker, LA; Satvat, E | 1 |
| Limebeer, CL; McCallum, AL; Parker, LA | 1 |
| Alvanzo, AA; Gruber, VA; Ma, Q; McCance-Katz, EF; Moody, DE; Morse, GD; Pade, PA; Prathikanti, S; Rainey, PM | 1 |
| Eriksen, GS; Gjerstad, J; Jacobsen, LM; Mahmood, A; Pedersen, LM | 1 |
| Bruce, RD; Custodio, JM; Friedland, GH; Kearney, BP; Ramanathan, S; Rhee, MS; Wei, LX; Winkle, P | 1 |
| Cravatt, BF; Damaj, MI; Gamage, TF; Ignatowska-Jankowska, BM; Lichtman, AH; Muldoon, PP | 1 |
| Cravatt, BF; Limebeer, CL; Millett, G; Niphakis, MJ; Parker, LA; Petrie, GN; Rock, EM; Wills, KL | 1 |
1 trial(s) available for carbamates and naloxone
| Article | Year |
|---|---|
Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir.
Topics: Anti-HIV Agents; Area Under Curve; Buprenorphine; Carbamates; Darunavir; Drug Interactions; Female; Furans; Half-Life; History, 16th Century; History, 17th Century; Humans; Male; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Organophosphates; Protease Inhibitors; Ritonavir; Sulfonamides | 2012 |
9 other study(ies) available for carbamates and naloxone
| Article | Year |
|---|---|
Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.
Topics: 5-Hydroxytryptophan; Analgesics; Animals; Brain Chemistry; Carbamates; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Drug Combinations; Drug Synergism; Female; Fenclonine; Hot Temperature; Male; Methyltyrosines; Mice; Morphine; Nalorphine; Naloxone; Oxotremorine; Physostigmine; Reaction Time; Reserpine; Serotonin; Stimulation, Chemical; Tremorine | 1971 |
[New central analgesic-acting triaminopyridines].
Topics: Aminopyridines; Analgesics; Animals; Ataxia; Carbamates; Dogs; Drug Synergism; Electroshock; Ethanol; Female; Hexobarbital; Male; Mice; Motor Activity; Naloxone; Rats | 1993 |
Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Topics: Analgesics, Opioid; Animals; Benzamides; Benzoxazines; Cannabinoids; Carbamates; Dopamine; Dopamine Antagonists; Exploratory Behavior; Flupenthixol; Male; Morphine; Morpholines; Motor Activity; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Play and Playthings; Pyrazoles; Rats; Rats, Wistar; Receptors, Dopamine; Reward; Rimonabant; Social Behavior | 2008 |
FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Topics: Amidohydrolases; Animals; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Choice Behavior; Conditioning, Psychological; Dietary Sucrose; Extinction, Psychological; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Rimonabant; Species Specificity; Substance Withdrawal Syndrome | 2009 |
Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
Topics: Amidohydrolases; Animals; Avoidance Learning; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Conditioning, Classical; Endocannabinoids; Enzyme Inhibitors; Male; Morphine; Naloxone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2010 |
Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP).
Topics: Amidohydrolases; Animals; Benzamides; Biophysics; Carbamates; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Female; Gene Expression Regulation; Long-Term Potentiation; Naloxone; Narcotic Antagonists; Nerve Fibers; Nociception; Rats; Rats, Sprague-Dawley; Spinal Cord; Time Factors | 2012 |
The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment.
Topics: Adult; Anti-Retroviral Agents; Area Under Curve; Buprenorphine; Carbamates; Cobicistat; Drug Interactions; Female; HIV Infections; HIV Seronegativity; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Quinolones; Thiazoles | 2013 |
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
Topics: Acetamides; Amidohydrolases; Animals; Avoidance Learning; Benzodioxoles; Carbamates; Conditioning, Psychological; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Male; Mice; Monoacylglycerol Lipases; Morphine; Naloxone; Piperidines; Pyridines; Substance Withdrawal Syndrome | 2015 |
Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats.
Topics: Amygdala; Analysis of Variance; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Carbamates; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Endocannabinoids; Glycerides; Male; Monoacylglycerol Lipases; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Succinimides | 2016 |